Cataract operations 2020 | Cataract operations 2019 | |||
---|---|---|---|---|
Type of complication | SIP-6 Operations week 6–11 (N = 15,141) | SIP+6 Operations week 20–25 (N = 15,544) | Operations week 6–11 (N = 21,270) | Operations week 20–25 (N = 19,087) |
Intraoperative | ||||
Posterior capsular rupture with vitreous loss, N (%) | 27 (0.18) | 25 (0.16) | 50 (0.24) | 32 (0.17) |
Posterior capsular rupture without vitreous loss, N (%) | 25 (0.17) | 25 (0.16) | 39 (0.18) | 46 (0.24) |
Iris prolapse, N (%) | 18 (0.12) | 23 (0.15) | 29 (0.14) | 25 (0.13) |
Zonulolysis, N (%) | 16 (0.11) | 23 (0.15) | 30 (0.14) | 30 (0.16) |
Capsulorhexis tear out, N (%) | 24 (0.16) | 27 (0.17) | 22 (0.10) | 30 (0.16) |
Dropped nucleus, N (%) | 12 (0.08) | 6 (0.04) | 8 (0.04) | 10 (0.05) |
Others, N (%) | 30 (0,20) | 18 (0,12) | 28 (0,13) | 30 (0,16) |
Total, N (%) | 152 (100) | 147 (100) | 206 (100) | 203 (100) |
Postoperative | ||||
Persistent corneal edema, N (%) | 16 (0.11) | 12 (0.08) | 23 (0.11) | 29 (0.15) |
Cystoid macular edema, N (%) | 71 (0.47) | 48 (0.31) | 94 (0.44) | 79 (0.41) |
Endophthalmitis, N (%) | 2 (0.01) | 3 (0.02) | 6 (0.03) | 2 (0.01) |
Others, N (%) | 76 (0.50) | 48 (0.31) | 74 (0.35) | 78 (0.41) |
Total, N (%) | 165 (100) | 111 (100) | 197 (100) | 188 (100) |